You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

muscle-invasive, non-metastatic

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Muscle Invasive Bladder Carcinoma Trial (FL-101)

Withdrawn
  • Muscle Invasive Bladder Carcinoma
  • (no location specified)
Aug 17, 2022

Muscle-Invasive Bladder Carcinoma Trial in Roma (Nivolumab, Nab paclitaxel, Cisplatin)

Not yet recruiting
  • Muscle-Invasive Bladder Carcinoma
  • Roma, Italy
    Roberto iacovelli
Jan 10, 2022

High-risk Non-muscle Invasive Bladder Cancer Trial (SHR-2005)

Not yet recruiting
  • High-risk Non-muscle Invasive Bladder Cancer
  • (no location specified)
Oct 25, 2023

Non-muscle Invasive Bladder Cancer Trial in Chengdu (RC48-ADC)

Not yet recruiting
  • Non-muscle Invasive Bladder Cancer
  • Chengdu, Sichuan, China
    West China Hospital
Aug 10, 2023

Tool in Non-muscle Invasive Bladder Cancer (NMIBC)

Not yet recruiting
  • Non-muscle-invasive Bladder Cancer
    • (no location specified)
    Apr 11, 2023

    Uromonitor asBiomarker for Optimization of NMIBC Management by

    Not yet recruiting
    • Non-muscle-invasive Bladder Cancer
      • (no location specified)
      May 9, 2023

      Neutrophils to Lymphocytes Ratio in Predicting Response to BCG

      Completed
      • Urinary Bladder Cancer
      • +4 more
      • Neutrophil to lymphocyte ratio
      • Cairo, Egypt
        Ain Shams university
      Jul 15, 2023

      Bladder Cancer Trial in Tianjin (Cadonilimab)

      Recruiting
      • Bladder Cancer
      • Tianjin, Tianjin, China
        Tianjin Medical University Second Hospital
      Aug 23, 2023

      Non-Muscle- Invasive Bladder Cancer Trial (Durvalumab, BCG)

      Not yet recruiting
      • Non-Muscle- Invasive Bladder Cancer
      • Durvalumab
      • BCG
      • (no location specified)
      Jul 5, 2023

      Bladder Cancer Trial in Jinan (Pseudomonas aeruginosa)

      Recruiting
      • Bladder Cancer
      • Pseudomonas aeruginosa
      • Jinan, Shandong, China
        Qilu hospital
      Jul 26, 2023

      Non-muscle-invasive Bladder Cancer Trial (Cystoscopy, Bladder EpiCheck urine test, Xpert Bladder Cancer Monitor urine test)

      Not yet recruiting
      • Non-muscle-invasive Bladder Cancer
      • Cystoscopy
      • +2 more
      • (no location specified)
      Apr 4, 2023

      Intravesical N-803 Plus BCG in BCG-Naive Non-Muscle Invasive

      Recruiting
      • Non Muscle Invasive Bladder Cancer
      • N803 plus Bacillus Calmette-Guerin (BCG)
      • Honolulu, Hawaii
        Island Urology
      Aug 7, 2023

      Non-Muscle Invasive Bladder Cancer, HER2 Trial (RC48, Tislelizumab)

      Not yet recruiting
      • Non-Muscle Invasive Bladder Cancer
      • HER2
      • (no location specified)
      Jul 16, 2023

      Non-muscle Invasive Bladder Cancer Trial (TARA-002)

      Not yet recruiting
      • Non-muscle Invasive Bladder Cancer
      • TARA-002
      • (no location specified)
      Jul 14, 2023

      Mood Alterations in Non-Muscle Invasive Bladder Cancer Treated

      Recruiting
      • Non-Muscle Invasive Bladder Cancer
      • Questionnaires
      • +4 more
      • Washington, District of Columbia
        Sibley Memorial Hospital
      Jan 17, 2023

      BCDx for Monitoring of Recurrence in Non-Muscle Invasive Bladder

      Recruiting
      • Bladder Cancer
        • Little Rock, Arkansas
        • +2 more
        Aug 6, 2023

        Non-muscle-invasive Bladder Cancer, Non-Muscle Invasive Bladder Urothelial Carcinoma, High Risk Non-Muscle Invasive Bladder

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
        • +2 more
        • PDD-TURBT with hexaminolevulinate (Hexvix®)
        • Power Led Saphira (TM) from KARL STORZ
        • (no location specified)
        Jul 24, 2023

        Non-muscle-invasive Bladder Cancer Trial in Shanghai (BCG combined with Tislelizumab)

        Not yet recruiting
        • Non-muscle-invasive Bladder Cancer
        • BCG combined with Tislelizumab
        • Shanghai, Shanghai, China
          Ruijin Hospital, Shanghai Jiaotong University School of Medicine
        Oct 12, 2022

        Non-Muscle Invasive Bladder Cancer, Self Efficacy, Smoking Behaviors Trial in Istanbul (Behavioral: Motivational Interviewing

        Not yet recruiting
        • Non-Muscle Invasive Bladder Cancer
        • +4 more
        • Behavioral: Motivational Interviewing with WhatsApp video call
        • Istanbul, Turkey
          İrem Nur Ozdemir
        Jan 20, 2023

        Bladder Cancer Trial in Roskilde (Urine test)

        Recruiting
        • Bladder Cancer
          • Roskilde, Denmark
            Zealand University Hospital
          Oct 5, 2022

          Lung Diseases Trial in João Pessoa (Active non-invasive stimulation and inspiratory muscle training, Sham compatorator and

          Recruiting
          • Lung Diseases
          • Active non-invasive stimulation and inspiratory muscle training
          • Sham compatorator and inspiratory muscle training
          • João Pessoa, Paraiba, Brazil
            Federal University of Paraiba
          May 23, 2023

          High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8

          Not yet recruiting
          • High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
          • +3 more
          • PD-L1/IDO Peptide Vaccine
          • Pembrolizumab
          • Sacramento, California
            University of California Davis Comprehensive Cancer Center
          Apr 24, 2023

          Sensitivity of Multiparametric MRI in Differentiation Between

          Recruiting
          • Cancer, Bladder
          • multiparametric MRI on the bladder
          • diagnostic cystoscopy +/- TURBT
          • Badr, Cairo, Egypt
            Faculty of medicine, Helwan university
          Jun 26, 2022

          Brazilian Reality of Urinary Bladder Cancers - BRA-BLADDER

          Recruiting
          • Urothelial Carcinoma
          • +2 more
            • Recife, Pernambuco, Brazil
            • +6 more
            Jul 11, 2023

            Bladder Urothelial Carcinoma, Clear Cell Renal Cell Carcinoma, Malignant Urinary System Tumor Trial in Houston (procedure,

            Active, not recruiting
            • Bladder Urothelial Carcinoma
            • +4 more
            • Biopsy
            • +4 more
            • Houston, Texas
              M D Anderson Cancer Center
            Jul 18, 2022